BIOCRYST PHARMACEUTICALS INC (59) | Uncategorized (26)

Recent Contracts

EX-10.76 EX-10.101 EX-10.102 EX-10.103 EX-10.104 EX-21 EX-23 EX-31.1 EX-31.2 EX-32.1 EX-32.2 EX-101 EX-104 (Filed With SEC on February 28, 2022)
EX-10.72 EX-10.76 EX-10.101 EX-10.102 EX-10.103 EX-10.104 EX-21 EX-23 EX-31.1 EX-31.2 EX-32.1 EX-32.2 EX-101 EX-104 (Filed With SEC on February 28, 2022)
EX-10.14 EX-10.72 EX-10.76 EX-10.101 EX-10.102 EX-10.103 EX-10.104 EX-21 EX-23 EX-31.1 EX-31.2 EX-32.1 EX-32.2 EX-101 EX-104 (Filed With SEC on February 28, 2022)
(Filed With SEC on November 4, 2021)
Amendment, dated August 27, 2021, to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services (Filed With SEC on September 1, 2021)
(Filed With SEC on August 9, 2021)
(Filed With SEC on August 9, 2021)
(Filed With SEC on August 9, 2021)
(Filed With SEC on August 9, 2021)
(Filed With SEC on May 7, 2021)
(Filed With SEC on November 6, 2020)
(Filed With SEC on November 6, 2020)
(Filed With SEC on November 6, 2020)
(Filed With SEC on November 6, 2020)
(Filed With SEC on November 6, 2020)
Amendment, dated August 31, 2020, to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services (Filed With SEC on September 3, 2020)
(Filed With SEC on August 10, 2020)
Cash and cash equivalents (Filed With SEC on May 11, 2020)
Cash and cash equivalents (Filed With SEC on May 11, 2020)
Drug/Drug Candidate (Filed With SEC on March 13, 2020)
Drug/Drug Candidate (Filed With SEC on March 13, 2020)
Cash and cash equivalents (Filed With SEC on November 8, 2019)
Cash and cash equivalents (Filed With SEC on November 8, 2019)
Amendment dated as of September 23, 2019 to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services (Filed With SEC on September 26, 2019)
Cash and cash equivalents (Filed With SEC on August 8, 2019)
Cash and cash equivalents (Filed With SEC on May 9, 2019)